Join to View Full Profile
1220 Holcombe BlvdStop 97Houston, TX 77030
Phone+1 817-805-2839
Fax+1 713-745-7296
Dr. Koay is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 2010 - 2014
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2009 - 2010
Baylor College of MedicineClass of 2009
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2022 - 2027
GA State Medical License 2023 - 2026
TN State Medical License 2022 - 2026
AL State Medical License 2023 - 2025
LA State Medical License 2022 - 2025
MS State Medical License 2022 - 2025
American Board of Radiology Radiation Oncology- Join now to see all
Clinical Trials
- Radiation Therapy With Protons or Photons in Treating Patients With Liver Cancer Start of enrollment: 2018 Jan 26
- Hypofractionated Radiation Therapy and Bintrafusp Alfa for the Treatment of Advanced Intrahepatic Cholangiocarcinoma Start of enrollment: 2021 Aug 31
- Customized 3D Printed Oral Stents During Head and Neck Radiotherapy Start of enrollment: 2021 May 26
- Join now to see all
Publications & Presentations
PubMed
- Emerging evidence-based role for external-beam radiation therapy in hepatocellular carcinoma.Stephanie O Dudzinski, Neil B Newman, Jeff McIntyre, Reena Engineer, Nina N Sanford
The Lancet. Gastroenterology & Hepatology. 2025-04-01 - Erratum to: Defining Minimum Treatment Parameters of Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma: An Expert Consensus. Yanagihara TK, Tepper J...Ted K Yanagihara, Joel E Tepper, Andrew M Moon, Aisling Barry, Meritxell Molla
Practical Radiation Oncology. 2025-03-28 - A phase I/II trial of avelumab combinations with ivuxolimab, utomilumab, and radiation therapy in patients with advanced gastrointestinal malignancies.Jibran Ahmed, Anne Knisely, Carlos Torrado, Bettzy Stephen, Yali Yang
The Oncologist. 2025-03-10
Journal Articles
- A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal AdenocarcinomaShun Yu, Deyali Chatterjee, Rong Ye, Prajnan Das, Naveen Garg, Robert A Wolff, Huamin Wang, Eugene J Koay, Gauri R Varadhachary, Christopher H Crane, Milind Javle, Jef..., Clinical Cancer Research
Press Mentions
MD Anderson to Evaluate ARTIDIS’ Nanomechanical Technology for Tumor AnalysisOctober 3rd, 2022- MD Anderson and ARTIDIS Announce Strategic Alliance to Advance Nanomechanical Technology Platform for Optimizing Cancer TreatmentOctober 3rd, 2022
- Nanobiotix Announces Publication of New Clinical Case Study Highlighting First Patient Experience of NBTXR3 Treatment for Pancreatic CancerFebruary 9th, 2022
- Join now to see all
Grant Support
- Circulating Biomarkers and Imaging for Early Detection of Pancreatic CancerUNIVERSITY OF TX MD ANDERSON CAN CTR2018–2029
- Circulating Biomarkers and Imaging for Early Detection of Pancreatic CancerUNIVERSITY OF TX MD ANDERSON CAN CTR2018–2029
- Risk Stratification for and Early Detection of Liver CancerBAYLOR COLLEGE OF MEDICINE2018–2028
- Risk Stratification for and Early Detection of Liver CancerBAYLOR COLLEGE OF MEDICINE2018–2028
- Early Detection of Hepatocellular CarcinomaUNIVERSITY OF TX MD ANDERSON CAN CTR2016–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
